How GSK is Powering R&D with Data, Digital and Tech

Michael Montello, MBA, GSK’s SVP R&D Digital and Tech, discusses NASA, Artificial Intelligence and pharma’s transition to using big data and in silico modeling to boost the probability of success of new medicines and vaccines.